Demographic considerations in tacrolimus pharmacokinetics.

[1]  R. Reder,et al.  Pharmacokinetic‐pharmacodynamic relationships of controlled‐release oxycodone , 1996, Clinical pharmacology and therapeutics.

[2]  P. Ward,et al.  Effect of age and gender on tirilazad pharmacokinetics in humans , 1994, Clinical pharmacology and therapy.

[3]  D. Faulds,et al.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. , 1993, Drugs.

[4]  B. Kahan,et al.  Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation , 1993, Clinical pharmacology and therapeutics.

[5]  B D Kahan,et al.  Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: Racial differences in bioavailability , 1992, Clinical pharmacology and therapeutics.

[6]  C. Hunt,et al.  Effect of age and gender on the activity of human hepatic CYP3A. , 1992, Biochemical pharmacology.

[7]  C. V. van Buren,et al.  DEMOGRAPHIC FACTORS AFFECTING THE PHARMACOKINETICS OF CYCLOSPORINE ESTIMATED BY RADIOIMMUNOASSAY , 1986, Transplantation.

[8]  K. Wilson.  Sex-Related Differences in Drug Disposition in Man , 1984, Clinical pharmacokinetics.

[9]  T. Kamataki,et al.  Cytochrome P-450 as a determinant of sex difference of drug metabolism in the rat. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[10]  R. Kato,et al.  Sex-related differences in drug metabolism. , 1974, Drug metabolism reviews.